1. Home
  2. XE vs ATRC Comparison

XE vs ATRC Comparison

Compare XE & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo X-Energy Inc. Class A Common Stock

XE

X-Energy Inc. Class A Common Stock

N/A

Current Price

$9.72

Market Cap

3.1B

Sector

Industrials

ML Signal

N/A

Logo AtriCure Inc.

ATRC

AtriCure Inc.

N/A

Current Price

$54.59

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XE
ATRC
Founded
2009
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
2026
2005

Fundamental Metrics

Financial Performance
Metric
XE
ATRC
Price
$9.72
$54.59
Analyst Decision
Buy
Buy
Analyst Count
11
10
Target Price
$25.72
★ $64.89
AVG Volume (30 Days)
★ 5.2M
686.8K
Earning Date
11-12-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 74.74
EPS
N/A
★ 0.27
Revenue
N/A
★ $201,630,000.00
Revenue This Year
$132.70
$13.81
Revenue Next Year
$293.45
$12.18
P/E Ratio
★ N/A
$204.96
Revenue Growth
N/A
★ 15.40
52 Week Low
$8.68
$25.36
52 Week High
$23.99
$66.02

Technical Indicators

Market Signals
Indicator
XE
ATRC
Relative Strength Index (RSI) 37.26 42.80
Support Level $8.68 $51.63
Resistance Level $12.08 $61.70
Average True Range (ATR) 0.98 3.00
MACD 0.08 -0.73
Stochastic Oscillator 33.82 8.81

Price Performance

Historical Comparison
XE
ATRC

About XE X-Energy Inc. Class A Common Stock

X-Energy Inc operates as a designer of small modular nuclear reactors (SMRs) and nuclear fuel technologies. Its products include the Xe-100 high-temperature gas-cooled reactor and TRISO-X particle fuel, which are being developed for applications in grid power, industrial facilities, and artificial intelligence infrastructure.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: